Clinical Trial Update: A Trial of Cervidil for Outpatient Pre-induction of Cervical Ripening [Phase 3]

View source ↗

Summary

Phase 3 trial of Cervidil for outpatient cervical ripening in induction of labor was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Induction of Labor Affected Fetus Newborn

Drugs mentioned

• Cervidil (dinoprostone)

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Induction of Labor Affected Fetus / Newborn | Phase 3 | Status: TERMINATED | Results posted: 2021-09-05